Overview

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Status:
Completed
Trial end date:
2019-05-08
Target enrollment:
Participant gender:
Summary
This is a Phase 2a, multi-center, open-label study of PTI-125 in mild-to-moderate Alzheimer's disease patients.
Phase:
Phase 2
Details
Lead Sponsor:
Pain Therapeutics
Collaborators:
National Institute on Aging (NIA)
National Institutes of Health (NIH)